Compare Stryker Corporation (SYK) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Stryker Corporation trades at $277.33 (market cap $106.24B), while YieldMax Universe Fund of Option Income ETFs trades at $7.61 (market cap $364M). The key difference: Stryker Corporation is far larger — about 291.9× YieldMax Universe Fund of Option Income ETFs's market cap, and Stryker Corporation pays a 1.27% dividend while YieldMax Universe Fund of Option Income ETFs pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 21 Days and YieldMax Universe Fund of Option Income ETFs for 56 Days on average.
| SYK | YMAX | |
|---|---|---|
Market Cap | $106.24B | $364M |
Volume | 2,982,001 | 1,181,378 |
Sector | Health | Income / Options Overlay |
52-Week High | $388.35 | $12.98 |
52-Week Low | $269.75 | $7.27 |
Typical Hold Time | 21 Days | 56 Days |
Enterprise Value | $117.70B | — |
Dividend Yield | 1.27% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
YMAX trades at $7.61, up 1.06% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF maintains a high distribution yield, paying weekly dividends, though recent news highlights concerns about net asset value erosion. Key support is at $7, with resistance at $8.
The outlook is cautious due to structural risks from the fund-of-funds fee structure and declining share price despite distributions. Opportunities exist for income-focused investors seeking high yield, but principal erosion remains a significant risk. Analyst sentiment is neutral to bearish, emphasizing sustainability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
